Publication | Closed Access
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis
32
Citations
46
References
2018
Year
Inflammatory Lung DiseaseLung InflammationMedicineCannabidiol Aminoquinone Vce-004.8Pulmonary PharmacologyTopical DrugPulmonary FibrosisSkin PharmacologyPharmacotherapyDermatologyBleomycin-induced SkinPharmacologyOral FormulationDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1